Wednesday, January 27, 2010

CVS Diseases

CVS Disease

Hypertension
Chronically elevated BP

Presentation
Usually asymptomatic (except malignant HTN)
Cardiac enlargement
Features of underlying causes, eg: radiofemoral delay, palpable kidney

Causes
Primary/Essential/Idiopathic -95%
Secondary
1. Renal
  • Intrinsic renal disease(75%)- glomerulonephritis, PAN, systemic scelosis, chronic pyelonephritis, PKD
  • Renovascular disease(25%) –atheromatous,  fibromascular dysplasia
  • Renin producing tumour
2. Endocrine
  • Thyroid disease – hyperparathyroidism
  • Adrenal – Cushing, Conn (Primary aldosternism), Phaechromocytoma
3. Others
  • Coarctation of aorta, pregnancy, sleep apnea, stress, drugs(alcohol, cocaine)

Investigation
U&E
Creatinine
cholesterol
glucose
ECG
urine analysis
Specific: (exlclude secondary cause)
  • renal US
  • renal arteriography
  • 24h ambulatory BP monitoring (always lower, add-on 12/7 mmHg)

Hypertensive retinopathy
I   Tortuous arteries with thick shiny walls (silver or copper wiring)
II  A-V nipping (narrowing where arteries cross veins)
III Flame haemorrhages and cotton wool spots
IV Papillodema


Management

Category
Systolic (mmHg)
Diastolic (mmHg)

Normal
<120
<80
-
Pre-hypertension
120-139
80-89
Reassess in 5 years, advice on healthy lifestyle
Stage 1
140-159
90-99
CHD+stroke risk

Stage 2
>160
>100

isolated systolic hypertension
>140
<90




Heart Failure
Problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs.

Presentation

Left ventricular failure
Right ventricular failure
Symptoms
  • Exertional dyspnoea
  • orthopnoea
  • PND
  • nocturnal cough + pink frothy sputum
  • tachypnoea (Cheyn-Stokes
  • Crackles at lung bases (Pulmonary oedema)
  • +ve abdominojugular test
  • S3, apex displaced lateral to mid-clavicular line
  • Peripheral oedema
  • abd. distention(ascites)
  • anorexia
  • nausea
  • JVP ↑
  • Hepatomegaly

New York Classification of HF
Class I  asymptomatic
Class II symptoms at routine activity
Class III symptoms at less than routine activity
Class IV symptoms at rest

Causes
Heart disease with anaemia or pregannacy
hyperthyroidism
Paget’s disease
atreoalvenous malformation

Risk Factor
Previous MI
Hx of arrhythmia, valvular/ vascular disease
HTN
Family hx of cardiomyopathy
DM
Obesity
Prior exposure to cardiotoxic agents

Investigation
FBC
U&E
B-type Natriuretic Peptide(BNP)
  • secreted by the heart in response to excessive stretching of heart muscle cells
  • 100pg/ml, HF likely, sensitivity = 90%, specificity = 76%
  • ↓ aldosterone, endothelin-1 (vasoconstrictor)&  noradrenaline, ↑diuresis, lusitropic, anti-fibrotic, anti-remodelling
  • Caveats: lower with ↑ BMI, affected by renal fn, ↓ by ACEi, diuretics,
ECG –usually shows abnormality (causes) – MI
If ECG and BNP are normal, heart failure is unlikely
Echocardiography – not diagnostic, indicate the causes (MI, valvular disease, LV dysfunction), performed if BNP ↑. Findings:
Ejection fraction: EDV-ESV > 50% + 5%
valvular disease
Diastolic dysfunction - ↑ wall thickness, LA dimension
CXR- eg: features in LVF:
  • Alveolar oedema – perihilar bat’s wing shadowing
  • Kerley B lines (interstitial oedema)
  • Cardiomegaly -cardiothoracic ratio >50%
  • Dilated prominent upper lobe vessels
  • Pleural Effusion
Cardiac CT, MRI
Coronary angiogram

Management
Acute HF (emergency)
Chronic HF
  • ABC
  • Sit pt upright
  • O2 100% if no lung disease
  • IV access and monitor ECG, treat any arrhythmia.
  • Investigation while treating
  • Diamorphine 2.5-5mg IV slowly, caution in lover failure and COPD
  • Furosemide 40-80mg IV slowly, larger doses in AKI
  • GTN spray 2 puffs SL, don’t give if systolic BP < 90mmHg
  • Necessary investigation, hx and exam
  • if systolic BP > 100mmHg, start a nitrate infusion, isosorbide dinitrate 2-10mg/h IVI, keep systolic BP >90mmHg
  • If worsens, further dose of furosemide 40-8-mg. Consider ventilation, eg. CPAP, get help
  • If systolic BP< 100mmHg, treat as cardiogenic shock, ie. consider a Swan-Ganz catheter and inotropic support

  • Treat the cause, eg. valve disease
  • Treat exacerbating factors, eg thyroid disease, infection, HTN
  • Avoid exacerbating factors- NSAIDs, verapamil
  • Stop smoking, eat less salt, maintain weight
  • Drugs: Diuretics, ACEi, B-Blocker, Spirinolactone, Digoxin, vasodilators
  • Intractiblable HF
- reassess the cause, compliance
- bed rest
- metolazone,frusemide, opiates, nitrates
- DVT prophylaxis: heparin and TED
- consider heart transplant. Jarvik thumb-sized titanium axial flow impeller pump.



Valve Disease
 

Mitral Stenosis
Mitral Regurgitation
Aortic stenosis
Aortic regurgitation
Causes
Rheumatic, congenital parachute valve- all chordate insert into 1 papillary muscle., mucopolysacharide
Functional (LV dilatation) annular calcification, Rheumatic, IE, HOCM
senile calcification, bicuspid valve, William’s syndrome
congenital, rheumatic fever, IE, RA, aortic root disease
Symptoms
dyspnoea, PND, haemoptysis (ruptured bronchial vein), ascites
dyspnoea, fatigue
Exertional chest pain/dyspnoea/ syncope
Exertional dyspnoea, angina, palpitation
General
tachypnoea, mitral stenosis
tachypnoea
-
Marfan, ankylosin.  spondilytis
Pulse, BP
normal/↓
normal/ sharp upstroke
Pulse: Plateu/ anacrotic/ late peaking/ small volume
Pulse :collapsing, water hammer/ bisfirens
Corrigan sign
Palpation
tapping apex beat (palpable S1
displaced apex beat, pansystolic thrill, parasternal impulse
apex beat hyperdynaamic, slightly displaced
apex beat displaced & hyperkinetic
Auscultation
Loud S1,
mid-diastolic murmur over mitral area using bell, louder with isometric handgrib and left lateral position
Soft/ no S1
pansystolic murmur maximal at the apex and radiating to the axilla, louder with isometric handgrib and left lateral position
narrowly  split/ reversed S2
Ejection systolic murmur, radiates to carotid arteries, louder when pt squats rapidly from standing position
Soft S1
Early diastolic murmur, maximal at the left sternal border with diaphragm and pt leans forward in full expiration
Severe
valve area<1cm. longer murmur, early opening snap, soft S1
larger left ventricle, loud S3
valve area<1cm, valve gradient >50mmHg,delayed carotid upstroke,late peaking murmur
collapsing pulse, wide pulse pressure, soft A2, Austin Flint murmur, systolic 80mmHg > than diatolic BP
Complication
Pulm. HTN, emboli, pressure effct



Test
ECG(AF, P-mitrale if in sinus rhytm, RVH) CXR(large left atrial, pulm edema, valve calcification), Echo. Indication for cardiac catheter: prev. valvotomy, other valve disease, angina, severe pulm HTN
ECG(AF, P-mitrale if in sinus rhytm, RVH) CXR(large LA & LV), Echo, Doppler echo, cardiac catheterisation
ECG(P-mitrale, LVH, LAD, LBBB), CXR(LVH, calcified aortic valve), Echo: (dx, measure valve gradient) Cardiac cathter: LV function
ECG:(LVH), CXR; (cardiomegaly), Echo, cardiac catheter
Management
control AF, warfarin, diuretics. if fail:balloon valvuloplasty, open valvulotomy/valve replacement, penicillin for recurrent rheumatic fever if <30
Indication for surgey LVEF >60%, LVESD <45mm
symptomatic: Prompt valve replacement, except for unfit: percutaneous valvuloplasty. Asymptomatic: regular monitor Poor prognosis: 2-3y if angina,
Valve replacement



MYOCARDIAL INFARCTION

Pathophysiology
90% caused by artherosclerosis
nonatherosclerotic c in younger patients: infected cardiac valve through a patent foramen ovale (PFO), coronary occlusion secondary to vasculitis, primary coronary vasospasm (variant angina), cocaine use, or other factors leading to mismatch of oxygen supply and demand, as may occur with a significant gastrointestinal bleed.

Epidemiology
  • 5/1000 per year for ST segment elevation

  • African American, Hispanic, and white populations in the United States.
  • male, age 70 years when the sexes converge to equal incidence.
  • Premenopausal women appear to be somewhat protected from atherosclerosis, possibly owing to the effects of estrogen.
  • Incidence increases with age.
  • Most patients who develop an acute myocardial infarction are older than 60 years. Elderly people also tend to have higher rates of morbidity and mortality from their infarcts.

Risk Factor
  • Non modifiable: age, gender, family hisyory
  • Modifiable: smoking, hypertension, DM,, hyperlipidaemia, obesity, sedentery lifesyle
  • Controversial: stress, type A personality, ↑ of apoprotein A & fibrinogen, hyperinsulinaemia, homocystein, ACE genotype, cocaine

Presentation
  • acute central chest pain > 20min ass with sweatiness, nausea, SOB, palpitations.
  • Silent infarct in elderly and diabetics- syncope, pulmonary oedema, epigastric pain and vomiting, post-op hypotension, oliguria, acute confusional state, stroke, diabetic hyperglyceamic state
  • distress, anxiety, pallor, pulse & BP ↑ or ↓, S4, sign of heart failure (↑  JVP, S3 and basal crepitations) or a pansystolic mumur (papillary muscle dysruption, rupture)
  • low grade pyrexia
  • later: pericardial rub or peripheral oedema

Diagnostic criteria
WHO criteria: 2 out of 3
  1. Typical history of ischaemic type chest pain lasting for more than 20 minutes
  2. Changes in serial ECG tracings
  3. Rise and fall of serum cardiac biomarkers such as creatine kinase-MB fraction and troponin + typical symptoms, pathological Q waves, ST elevation or depression or coronary intervention are diagnostic of MI.

Investigation
ECG
  1. hyperacute (tall) t waves, ST elevation or new LBBB within hours of acute Q wave (transmural infarction). T wave inversion and development of pathological Q wave follows over hours to days.
  2. St depressiion, T inversion, non-specific changes, or normal
  3. normal in 20% of MI
CXR
Cardiomegaly, pulmonary odema, widened mediastinum (?aorta dissection)
Blood
FBC, U&E, glucose , lipids ,
Cardiac enzyme
(CK, AST, LDH, troponin) , CK is found in myocardial and skeletal muscle: ↑ in MI, after trauma, prolonged exercise, myositis, afro-carribeans, hypothermia, hypothyroidism
Check CK-MB isoenzyme levels if there is doubt as to the source (normal CK-MB:CK ratio <5%)
Troponin T better shows MI (peaks at 12-24H, elevated for >1wk) If normal >6h after onset of pain, and ECG mormal, risk of  missing  Mi is tiny (0.3%). peak post MI levels also help risk stratification.

Differential Diagnosis
Angina, pericarditis, myocarditis, aortic dissection, pulmonary embolism, PE, oesophageal reflux

Management
Pre-hosp
Arrange emergency ambulance.aSPIRIN 300MG chewed and GTN sublingual
Analgesia (morphine 5-10mg IV + metoclopramide 10mg IV (not IM- risk of bleeding)

Hospital
Morphine, O2, Aspirin, IVI
check for ST elevetaion

ST-segment elevation
No ST segment elevation
  • Thrombolysis or primary angioplasty
  • B-blocker eg. atenolol 5mg IV
  • ACEi (eg lisinopril 2.5mg) start in all normotensive pt within 24h of acute MI, especially if thre is clinical evidence of heart failure or echo evoidence of LV dysfunction
  • B-blocker eg. atenolol 5mg IV
  • LMWH (eg enoxaparin 1mg/kg/12H SC for 2-8d
  • Nitrates
  • High risk pt (persistent or recurrent ischaemia, St depression, diabetes, ↑troponin) require infusion of GPIIb/IIIa antagonist (eg tirofiban) and ideally urgent angiography. Aspirin + copidogrel considered for up to 12 months.
  • Low risk pt (no further pain, flat or inverted T waves, or normal ECG and negative troponin) can be discharged if a repeat troponin is negative. Treat medically and arranged for stress test, angiogram ect.

Subsequent management: bed rest for 48H, continuous ECG monitoring
  • Daily examination of heart, lungs anfd legs complications
  • Daily 12-lead ECG, U&E, cardiac enzymes for 2-3d
  • Prophylaxis against thromboembolism, eg heparin 5000u/12h, until,fully mobile. If large anterior MI, consider warfarin anticoagulation for 3months as prophylaxis against systemic emnolism from LV mural thrombus. Continue daily low-dose aspirin (75-150mg) -reduce vascular events (MI, stroke, vascular death) by 29%
  • oral B-blocker (metoprolol 50mg/6h decrease pulse <60, continue for at least 1 year. Long term- reduce mortality by 25% in pt who had previous MI. If CI: verapamil or diltiazem
  • ACEi in all pt ↓ 2y mortality by 25-30%
  • Statin - ↓ cholesterol for all pt or if total cholesterol >4mmol/L
  • discourage smoking, encourage exercise, treat DM, HTN and hyperlipidaemia
  • exercise EC: in risk stratification 3-4wk post MI, in non STEMI or troponin rise
  • if uncomplicated : discharged after 5-7d.
  • Return to work after 2M, x start post MI: airline traffic, divers. Lighter jobs. Diet: oily fish, veg, fibre, low in saturated fat. Exercise. Avoid sex for 1 month, avoid air travel for 2 months
  • Review symptoms at 5wks
  • Review at 3 months: check fasting lipids

Complications
Cardiac arrest
Unstable angina
bradycardia or heart block
Tachyarryhtmias
LVF/RVF
Pericarditis
DVT, PE, systemic embolism
Cardai tamponade
Mitral regurgitation, VSD
Late malignant ventricular arryhtmias
Dressler's syndrome – recurrent pericarditis
Left ventricular aneurysm

Mortality
50% deaths occur within 2h onset of symptom


ATRIAL FIBRILLATION
supraventricular tachyarrhythmia characterized by disorganized atrial electrical activity and progressive deterioration of atrial electromechanical function. absence of P waves; rapid oscillations (or fibrillatory [f] waves)

Epidemiology
5% of the population older than 69 years, 8% of persons older than 80 years.
stroke risk 2.5%

Causes
Heart failure/ischaemia, HTN, MI, mitral valve disease, PE, pneumonia
hyperthyroidism, alcohol, post-op, K+ and Mg+ ↓
rare: Cardiomyopathy, constrictive pericarditis, sick sinus syndrome, lung cancer, atrial myxoma, endocarditis, haemochromatosis, sarcoid, Lone AF= no cause found

Presentations
may be asymptomatic
chest pain, palpitations, SOB,or faintness
irregularly irregular pulse, the apical pulse rate is greater than the rate
variable S1 intensity
sign of LVF

Investigation
ECG – absent p waves, irregular QRS complex
Blood: U&E, cardiac enzyme, TFT
Echo to look for left atrial enlargement, mitral valve disease, poor LV function

Management
Acute AF (<AF)
Chronic AF
  • Treat associated illnesses (eg. MI, pneumonia)
  • control ventricular rate
  • heparin 5000-10000U IV to keep options for cardioversion even if the 48h timelimit is running out.
  • If the 48h has elapsed, cardioversion without anticoagulation is OK if TTE shows no intracardiac thrombus.
  • Cardioversion regimen: O2 → ITU/CCU → GA or IV sedation → 200J → 360J → 360J (monophasic; if 100J is tried 1st, it only works in 20%) relapses back into AF are common, and drug cardioversion is often preferred: amiodarone IVI . Alternative (if stable and no known IHD or WPW), flecainide (negative inotropes). Monitor ECG
Controlling ventricular rate:
  • diltiazem/ verapamil/metoprolol
  • digoxin, amiodarone

  • Control rate.=as good as rhythm control in ↓morbidity +mortality
  • Consider rhythm control if 1st episode or younger patient
  • Warfarin (INR 2-3), CI: bleeding diathesis, platelets < 50x109/L, BP>160/90 (consistently): compliance issues, pt choice
  • Aspirin if CI to warfarin or at  low risk of emboli
Controlling ventricular rate:
B-blocker or rate limiting CCB
if fail, add Digoxin (monotherapy only ok in sedentary pt), then consider amiodarone

Paroxysmal AF
Pill-in-the-pocket
If not,try B-blocker
If fails and no LV dysfunction, sotalol 40mg/12h. S/E:↑QT interval, so monitor QT
If LV sydfunction: amiodarone



INFECTIVE ENDOCARDITIS

Classifications
50% endocarditis occurs in normal valve. It follows acute course -present with heart failure
endocarditis occurs in abnormal valve → subacute course

Causes
  • Bacteraemia – dentistry, UTI, urinary catheterization, cystoscopy, resp infection, endoscopy
  • Colon cancer, gall bladder disease, skin disease, IV cannulation, surgery, abortion, fractures.
  • Streps viridans commonest(35-50%), enterococci, staph aureus/ epidermidis, diphteroids, HACEK group, Coxiella burnetti, chlamydia
  • Candida, aspergillus, Histoplasma
  • SLE (libman-Sacks endocarditis), malignancy

Presentations
  • septic signs: fever, rigors, night sweats, malaise, weight loss, anaemia, splennomegaly, clubbing
  • cardiac lesions: any new murmur, or change in the nature of pre-existing murmur
  • vegetation may cause valve destruction, and severe regurgitation, or valve obstruction.
  • An aortic root abscess causes prolongation of the P-R interval, and may lead to complete AV
  • Immune complex deposition: vasculitis may affect any vessel.
  • Microscopic haematuria,glomerulonephritis and ARF
  • Roth spots(boat shaped retinal haemorrhage with pale centre), splinter haemorrhage, Osler nodes, Janeway's lesion.
  • Embolic phenomena: abscess in relevant organ- brain, kidney, lung (in R-sided endocarditis)



Diagnosis
  • Blood cultures: take 3 sets at different time and from different site at peak fever. 85-90% are diagnosed from the first 2 sets. 10% culture negative.
  • Blood test: normochromic, normocytic anaemia, neutrophil leucocytosis, high ESR/CRP. Also check U&E, Mg, LFT
  • Urinalysis- microscopic haematuria
  • CXR(cardiomegaly)
  • ECG (prolonged P-R interval)
  • Echo TTE may show vegetation, but only if >2mm, TOE is more sensitive and better for visualizing mitral lesions and possible development of aortic root abscess.

Duke Criteria
Major Criteria
Minor Criteria
Positive blood culture
  • typical organism in 2 separate cultures or
  • persistently +ve blood cultures, eg 3 >12h apart (or majority if > 4)
Endocardium involved
  • +ve echocardiogram (vegetation, abscess, dehiscence of prosthetic valve)
  • new valvular regurgitation (change in murmur nor sufficient)
  • Predisposition (cardiac lesion, IV drug abuse)
  • Fever > 38C
  • Vascular/immunological signs
  • +ve blood culture that do not meet major criteria
  • +ve echocardiogram that does not meet major criteria
Definite IE: 2 major or 1 major and 3 minor or all 5 minor criteria

Management
  • Liase early with microbilogist and cardiologist
  • Empirical therapy: benzylpenicilin 1.2g/4h IV + gentamicin eg 1mg/kg/8h IV (serum peak 3-5mg/L & a pre-dose trough of <1mg/L) for 4wks. If acute, add flucloxacilin to cover staphylocicci
  • Enteroccoci: amoxicilin 1g/6h iv + gentamicin as above
  • Streptococci: benzylpenicilin 1.2g/4h IV 2-4wks, then amoxicilin 1g/8h PO for 2wks. Monitor minimum inhibitory concentration (MIC). Add gentamicin
  • Staphilococci : flucloxacilin 2g/6h IV + gentamicin as above IV. Treat for 6-8wks, stop gentamicin after 1wk. If prosthetic valve or MRSA suspected, substitute flucloxacilin with vancomicin + rifampicin
  • Coxiella: doxycilin 100mg/12h PO indefinitely + co-trimoxazole, rifampicin or ciprofloxacilin
  • Fungi: flucytosine 50mg/kg/6h IVI over 30min followed by fluconazole 50mg/24h PO (higher dose may be needed) Amphotericin if flucytosine or Aspergillus. Miconazole if renal fn is poor

No comments:

Designed by Irfan Ziad • Copyleft under Creative Commons Attribution • Watermark Template • Powered by Blogger